Amgen (1AMGN) Stock Statistics & Valuation Metrics
Total Valuation
Amgen has a market cap or net worth of EUR 224.83B. The enterprise value is EUR 240.31B.
- Market Cap
- EUR 224.83B
- Enterprise Value
- EUR 240.31B
Share Statistics
Amgen has 540,632,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 540,632,000
- Owned by Insiders
- 0.21%
- Owned by Institutions
- 58.99%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.89 and return on invested capital (ROIC) is 13.16%.
- Return on Equity (ROE)
- 0.89
- Return on Assets (ROA)
- 0.09
- Return on Invested Capital (ROIC)
- 13.16%
- Return on Capital Employed (ROCE)
- 0.16
- Revenue Per Employee
- 1.17M
- Profits Per Employee
- 244.79K
- Employee Count
- 31,500
- Asset Turnover
- 0.41
- Inventory Turnover
- 1.72
Valuation Ratios
The current PE Ratio of Amgen is 28.73. Amgen’s PEG ratio is 0.91.
- PE Ratio
- 28.73
- PS Ratio
- 6.61
- PB Ratio
- 21.53
- Price to FCF
- 24.76
- Price to Operating Cash Flow
- 20.17
- PEG Ratio
- 0.91
Income Statement
In the last 12 months, Amgen had revenue of 36.74B and earned 7.71B in profits. Earnings per share was 14.33.
- Revenue
- 36.74B
- Gross Profit
- 26.01B
- Operating Income
- 10.68B
- Pretax Income
- 8.98B
- Net Income
- 7.71B
- EBITDA
- 16.90B
- Earnings Per Share (EPS)
- 14.33
Cash Flow
In the last 12 months, operating cash flow was 12.48B and capital expenditures -2.30B, giving a free cash flow of 10.18B billion.
- Operating Cash Flow
- 12.48B
- Free Cash Flow
- 10.18B
- Free Cash Flow per Share
- 18.84
Dividends & Yields
Amgen pays an annual dividend of ―, resulting in a dividend yield of 2.01%
- Dividend Per Share
- ―
- Dividend Yield
- 2.01%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.04%
- Earnings Yield
- 3.47%
Stock Price Statistics
- Beta
- 0.15
- 52-Week Price Change
- 66.72%
- 50-Day Moving Average
- 367.18
- 200-Day Moving Average
- 322.04
- Relative Strength Index (RSI)
- 74.20
- Average Volume (3m)
- 55
Important Dates
Amgen upcoming earnings date is Nov 03, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 04, 2026
- Next Earnings Date
- Nov 03, 2026
- Ex-Dividend Date
- ―
Financial Position
Amgen as a current ratio of 1.14, with Debt / Equity ratio of 630.68%
- Current Ratio
- 1.14
- Quick Ratio
- 0.90
- Debt to Market Cap
- 0.31
- Net Debt to EBITDA
- 2.69
- Interest Coverage Ratio
- 3.88
Taxes
In the past 12 months, Amgen has paid 1.26B in taxes.
- Income Tax
- 1.26B
- Effective Tax Rate
- 0.14
Enterprise Valuation
Amgen EV to EBITDA ratio is 16.75, with an EV/FCF ratio of 29.02.
- EV to Sales
- 7.74
- EV to EBITDA
- 16.75
- EV to Free Cash Flow
- 29.02
- EV to Operating Cash Flow
- 23.66
Balance Sheet
Amgen has EUR 13.99B in cash and marketable securities with EUR 57.30B in debt, giving a net cash position of -EUR 43.31B billion.
- Cash & Marketable Securities
- EUR 13.99B
- Total Debt
- EUR 57.30B
- Net Cash
- -EUR 43.31B
- Net Cash Per Share
- -EUR 80.12
- Tangible Book Value Per Share
- -EUR 50.86
Margins
Gross margin is 72.65%, with operating margin of 33.18%, and net profit margin of 22.93%.
- Gross Margin
- 72.65%
- Operating Margin
- 33.18%
- Pretax Margin
- 26.98%
- Net Profit Margin
- 22.93%
- EBITDA Margin
- 46.22%
- EBIT Margin
- 33.98%
Analyst Forecast
The average price target for Amgen is EUR 364.72, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 364.72
- Price Target Upside
- 13.89% Downside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 27
- Revenue Growth Forecast
- 2.51%
- EPS Growth Forecast
- 23.07%
Scores
- Smart Score
- 6
- AI Score
- ―